MAPLE-HCM

MAPLE-HCM is currently recruiting participants to evaluate the safety and efficacy of an investigational drug for Hypertrophic Cardiomyopathy (HCM).  

MAPLE-HCM is a phase 3 placebo-controlled clinical trial researching the investigational drug called aficamten.

 Who

People diagnosed with HCM and who have started experiencing first symptoms of HCM within the last 24 months.

Where

Site locations are within the United States; this website is limited to providing information related to sites in this country. For more information, please visit https://clinicaltrials.gov (NCT05767346).

Travel Expenses

Volunteers who qualify to take part in the study may receive compensation for study related travel expenses.